BriaCell Therapeutics Corp.BriaCell Therapeutics Corp.BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

No trades
See on Supercharts

Key stats


Market capitalization
‪35.35 M‬USD
Dividend yield (indicated)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
Net income (FY)
Revenue (FY)
Shares float
Beta (1Y)
0.54

About BRIACELL THERAPEUTICS CORP


CEO
William V. Williams
Headquarters
West Vancouver
Founded
2006
FIGI
BBG00ZF3B328
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.